Publicação
Co-delivery of two anti-HIV drug nanocrystals from electrospun nanofibers
| Resumo: | TRUVADA is the only medication approved by FDA for pre-exposure prophylaxis of the HIV infection. They are tablets with fixed dosages of two antiretroviral compounds for daily oral uptake: Tenofovir disoproxil fumarate (TDF) and Emtricitabine (EMT) that are reverse transcriptase inhibitors. Objectives: Incorporate TDF and EMT drugs in polymeric nanofibers produced by electrospinning; chosen polymers were polyoxyethilene (PEO) and polycaprolactone (PCL). Characterize the nanofibers and study the in vitro release profile of the drugs. Evaluate the possibility of a topical administration of the loaded fibers , by rectal or genital route, for HIV infection prophylaxis. |
|---|---|
| Autores principais: | Malta, Rafaela |
| Outros Autores: | Neves, José das; Sarmento, Bruno; Machado, Raul; Lúcio, M.; Viseu, T. M. R. |
| Assunto: | HIV infection Tenofovir disoproxil fumarate (TDF) Emtricitabine (EMT) Electrospinning Polymeric nanofibers Controled drug delivery |
| Ano: | 2017 |
| País: | Portugal |
| Tipo de documento: | póster em conferência |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade do Minho |
| Idioma: | inglês |
| Origem: | RepositóriUM - Universidade do Minho |
| Resumo: | TRUVADA is the only medication approved by FDA for pre-exposure prophylaxis of the HIV infection. They are tablets with fixed dosages of two antiretroviral compounds for daily oral uptake: Tenofovir disoproxil fumarate (TDF) and Emtricitabine (EMT) that are reverse transcriptase inhibitors. Objectives: Incorporate TDF and EMT drugs in polymeric nanofibers produced by electrospinning; chosen polymers were polyoxyethilene (PEO) and polycaprolactone (PCL). Characterize the nanofibers and study the in vitro release profile of the drugs. Evaluate the possibility of a topical administration of the loaded fibers , by rectal or genital route, for HIV infection prophylaxis. |
|---|